Merck
MRK
#56
Rank
NZ$454.76 B
Marketcap
NZ$182.07
Share price
1.23%
Change (1 day)
5.40%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): NZ$13.10

According to Merck's latest financial reports the company's current EPS (TTM) is NZ$13.00. In 2024 the company made an earnings per share (EPS) of NZ$11.57 an increase over its 2023 EPS that were of NZ$0.26.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$13.1013.2%
2024NZ$11.574308.46%
2023NZ$0.26-97.32%
2022NZ$9.8110.92%
2021NZ$8.8584.68%
2020NZ$4.79-27.2%
2019NZ$6.5863.44%
2018NZ$4.03151.11%
2017NZ$1.60-54.58%
2016NZ$3.5330.21%
2015NZ$2.71-61.99%
2014NZ$7.13180.51%
2013NZ$2.54-31.82%
2012NZ$3.736.62%
2011NZ$3.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.95-77.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$17.88 37.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$35.13 170.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$5.09-60.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$6.35-51.20%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
NZ$6.16-52.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$1.08-91.70%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
NZ$12.60-3.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Abbott Laboratories
ABT
NZ$13.80 6.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$22.31 71.59%๐Ÿ‡บ๐Ÿ‡ธ USA